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Abstract
With the goal of creating a porphyrin we reacted isoquinol pyrrole, p-fluorobenzaldehyde, and boron
trifluoride etherate under appropriate conditions. Instead of a porphyrin being synthesized, we created
polyisoquinol pyrrole in high yield and with great absorption properties around 600nm. We characterized
this compound via UV/vis spectroscopy, proton NMR, and electrochemistry. The compound was then
reacted with [Ru(bipy)2Cl2] to create a cationic compound and this molecule was tested as a possible
photosensitizer for photodynamic therapy (PDT) but it was unable to photocleave plasmid DNA above
550nm. The original compound was then methylated and this new compound was also tested as a
photosensitizer. This complex was successful at photocleaving DNA above 550nm and appears to be a
promising photosensitizer.

Dedication
The author would like to dedicate his honors thesis to his family, especially his loving parents, Madeline
and Donald Versteeg for their constant support and undying love.

Table of Contents

Abstract

Title Page

Introduction

1

Experimental Section

3

Results and Discussion

6

Conclusions

13

Acknowledgements

14

References

14

Page |1

Introduction

Photodynamic therapy (PDT) has been known for many years but is currently
gaining popularity due to its ability to fight many different cancers with minimal
side effects. PDT is an efficient procedure for many different cancers ranging
from skin and esophageal, to bladder, breast, and lung cancer.1-3 Current
treatments for cancer like chemotherapy and radiation have negative side effects
that harm the patient. Conversely, PDT has few side effects, is minimally
invasive, and targets tumor cells due to their interaction with LDL and the
upregulation of LDL receptors on tumor cells.7 PDT requires three things; light, a
photosensitizer, and molecular oxygen which separately are harmless but together
can kill tumor cells.4 Clinically, the light can be added via a fiber optic cable to
directly irradiate the tumor.1 A photosensitizer is a molecule that absorbs light
and can transfer it to other compounds.16 When the photosensitizer gets excited
by the correct wavelength of light, an electron becomes excited to the triplet
state.16 When this happens, four things can occur. The electron can fall down to
the ground state and give off energy as fluorescence. There are three mechanisms
that can occur when the electron is excited, type I is when the electron gets
transferred to molecular oxygen and superoxide or other reactive oxygen species
are created.5 Type II reaction occurs when the electron falls to the ground state, it
transfers energy to triplet oxygen and creates singlet oxygen.5 This reaction
preferably occurs because the excited photosensitizer is in the triplet state and
ground oxygen is in the triplet state as well, so the energy transfer is easy.16
Singlet oxygen is both toxic in the cell and has a long half life, a little less than
0.04 μsec, and a radius of effect around 0.02 μm.5 This small radius ensures that
PDT is a very localized reaction. Type III reaction is where the photosensitizer
reacts directly with molecules in the cell by acting like an oxidizing agent.6 If the
photosensitizer is bound to DNA, the nucleotides will be affected, most likely
Guanine since it is the easiest nucleotide to oxidize. All three of these
mechanisms are toxic to the cell but type II is most sought after. It is believed
that singlet oxygen is what is toxic enough to kill the cell by reacting with cellular
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components so this is the most sought after mechanism for the photosensitizer to
undergo.12
The most well known, FDA approved, photosensitizer used is the
hematoporphyrin derivative Photofrin (porfimer sodium). Although Photofrin is
being used in the clinic, it has some disadvantages. These disadvantages include
long-lasting skin photosensitivity and low singlet oxygen production at 630nm.8
In addition, synthesis of Photofrin suffers from purification difficulties, dark
toxicity, low tissue penetration of the light, and a high concentration of compound
is required in order to be effective.13, 14 Due to the numerous issues with
Photofrin, new photosensitizers are very desirable and are currently being sought.
The ideal photosensitizer should have several properties. It should have minimal
dark toxicity, high quantum yield of singlet oxygen production, tumor specificity,
and absorption in the 700-800nm range.17 This red region is ideal since light
scattering is minimal, the depth of penetration is deeper than wavelengths that are
below 600nm (the range from 600-800nm is described as the PDT window), and
the photosensitizer still can be excited by the low energy of the wavelength.17, 18
Porphyrins are currently being researched as potential photosensitizers due to
their lack of dark toxicity, their strong absorption properties, and their tumor
affinity. Some porphyrins have already been proven to be more effective PDT
substitutes for Photofrin however the absorption spectrum of thse porphyrins
remains too high in energy and thus the required light cannot penetrate far into
tissue.11 An additional attribute of porphyrins is their nuclear localization and
specifically the ability of cationic porphyrins which have been shown to interact
with DNA.10-11 Since generic porphyrins are insoluble in water, and require
higher energy light to be activated, there is a need to synthesize new novel
porphyrins that overcome these obstacles.
In this report we describe our attempt create a novel cationic porphyrin and the
results of the synthesis. We describe the synthesis and characterization by 1H
NMR, UV/Vis spectroscopy, electrochemistry, and elemental analysis of a new
polyisoquinol pyrrole complex with good synthetic yield and absorption
properties. We investigate the ability of ruthenated and methylated derivative of

Page |3

the original complex to photocleave supercoiled plasmid DNA when irradiated
with low-energy. The ruthenated complex was successful at photocleaving DNA
above 420nm, but not above 550nm. The methylated complex was successful at
photocleaving DNA above 550nm which provides us with a photosensitizer that
can be excited using low energy light.

Experimental Section

Materials. A mercury arc lamp 300 watt [Newport Model 67005], 550nm filter
[Newport Model 10LWF-550-B], 420nm filter [Newport FSR-GG420] were used
for the photocleavage studies. Tris(hydroxymethyl)-aminoethane (Tris Base)
[Fischer], boric acid [Fischer], the plasmid pUC18 DNA [Bayou Biolabs],
Hydrazine [Aldrich], Acetonitrile [Acros], Methanol [Fischer], Ethylene Glcyol
[Acros], Methylene chloride [Fischer], Anhydrous methylene chloride [Acros], 5nitroisoquinoline [Acros], 4-fluorobanzaldehyde [Acros], Boron trifluoride
etherate [Acros], Trifluoroacetic acid [Acros], Electrophoresis grade Agarose low
EEO [Fischer}, Phosphazene base [Aldrich], Tetrabutylammonium
hexafluorophosphate (Bu4NPF6, used as supporting electrolyte for
electrochemistry) [Aldrich], ethyl isocyanoacetate [Acros], p-chloranil [Aldrich],
neutral silica gel [Selecto Scientific] were used for the synthesis and
electrochemical studies. All elemental analyses were performed by Atlantic
Microlab in Norcross, Ga. Mass spectrometry was performed by The Ohio State
University Mass Spectrometry and Proteomics facility. Cis-Ru(bipy)2Cl2 was
synthesized as previously described.19

Isoquinone pyrrole ester. Isoquinone pyrrole ester was synthesized as
previously stated.15 In a 250mL round bottom flask 2.32g (13.3 mmol) of 5nitroisoquinoline was added with 100mL of dry THF. Massed 2.00g (17.7 mmol)
of isocyanoacetate and then added it dropwise to the round bottom flask. Added
4.27mL (13.7 mmol) of phosphazene base and let the solution stir and reflux for
24 hours. The solution was black before and after refluxing. After the solution

Page |4

refluxed, 100mL of methylene chloride was added to wash it. Added 150mL of
deionized water to a separatory funnel and added the contents of the flask to the
funnel and shook it up. The contents separated and we collected the black lower
layer in a beaker. Added sodium sulfate to beaker to collect any excess water
molecules and then decanted the solution into another beaker and let the solvent
evaporate off. Column chromatography of the solid was performed using 1%
methanol in methylene chloride. Collected orange band as it came off and used a
rotator evaporator (rotovap) to remove the solvent. Collected the solid in the
beaker. The solid was vacuum filtered and washed with methylene chloride.
Final yield was 0.98 g.
Isoquinone pyrrole. This compound was created as previously stated.15 Started
the reaction by adding 0.90 g of isoquinoline ester into a three-necked round
bottom flask with 1.1 g of KOH and 20mL of ethylene glycol. Bubbled the flask
under nitrogen for ten minutes. Added 10 drops of hydrazine and refluxed at 195
degrees Celsius for 30 minutes (Under nitrogen still). Poured the mixture into
ice/water which causes precipitation and vacuum filtered the precipitate. Rinse
the precipitate with water and vacuum filter overnight. Final yield was 0.55 g.

Poly-isoquinone pyrrole. Placed 0.36 g (2.1 mmol) of isoquinone pyrrole and
100 microliters of dry methylene chloride in a three-neck flask and stirred the
solution under nitrogen. The flask was submerged in a dry ice/acetone bath.
Then 230 microliters (2.14 mmol) of p-fluorobenzaldehyde and 87 microliters
(0.69mmol) of boron trifluoride dietherate were added to the solution. The
solution was stirred under nitrogen in the dry ice/acetone bath for two hours while
being protected from light. After two hours, the flask was raised from the bath
and continued to stir overnight at room temperature while still being protected
from light. The next morning, we added 0.52 g of p-chloranil and continued
stirring at room temperature for one hour. Poured the solution into another round
bottom flask and rinsed the old flask with methylene chloride and then methanol.
Rotovapped the flask to remove the solvent. Using neutral silica gel with sand on
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top, we performed column chromatography on the mixture using a 90/10
methylene chloride methanol solution as eluent and collected a bright maroon
purplish band. Collected the solid and vacuum filtered it. Final yield was 0.11 g
of compound. Anal. Calcd For C. 73.57, H 4.84, N 15.36. Found: C 73.59, H
4.87, N 15.60. TOF MS ES+ (m/z; relative abundance): [C33H24N6O2] (537.9)

Ruthenation of poly-isoquinone pyrrole. Added 25 mg (0.050mmoles) of polyisoquinol pyrrole, 73 mg (0.15 mmoles) and 5 mL of glacial acetic acid into a
10mL round bottom flask. Reflux and stir under nitrogen for thirty minutes.
Rotovapped solution down and added 2 mL of ethanol. Refluxed and stirred
under nitrogen. Added excess ammomium hexafluorophosphate to 125 mL of
water. Added reluxed product to solution and a red-brown precipitate . Vacuum
filtered overnight. Dissolved with a little acetonitrile and then added solution to
diethyl ether. Vacuum filtered again and collected 74 mg. Calculated for
[C93H73O2N18Cl3F18P3Ru3·2H2O] C, 47.05; H, 3.27; N, 10.62; F, 15.20 Found:
C, 46.92; H, 3.25; N, 10.21; F, 15.22

Methylation of poly-isoquinone pyrrole. Place 1μL of DMF; 20 ml of
methylene chloride, 12 mg (.0223mmoles) of poly isoquinol pyrrole, and 170 μL
(1.115 mmoles) of methyl tosylate into a 50mL round bottom flask. Let stir at
room temperature then reflux for 30 minutes. Gravity filtered it, a purple
precipitate was left while the filtrate was bright red. Washed through with
ethanol, then let evaporate to collect the solid. Deep purple solid was too hard to
scrap so we used two mL of DMSO and 23mL water to dissolve and dilute
product. Diluted to 100mL to a concentration of 74 μM. Anal. Calcd For C,
62.81; H, 4.96; N, 7.52. Found: C, 62.51; H, 4.85; N, 7.67. [C57H54N6O11S3]
NMR Spectroscopy. 1H NMR was performed by a Bruker 300MHz
spectrometer using CDCl3 as the solvent and TMS as the internal standard.
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Electronic spectroscopy. UV/vis spectra were recorded at room temperature
using a Schimadzu 1501 photodiode array spectrophotometer with 2nm
resolution. Samples were run in a 1cm quartz cuvette.

Electrochemistry. Cyclic voltammograms were recorded using a onecompartment, three electrode cell, CH-Instruments, equipped with a platinum
wire auxiliary electrode. The working electrode was a 2.0 mm diameter platinum
disk from CH-Instruments. The working electrode was polished first using 0.30
μm alumina polish (Buehler) and then sonicated for 20s prior to use. Potentials
were referenced to a Ag/Ag+ (0.010M, in acetonitrile) electrode. The supporting
electrolyte was 0.1M tetrabutylammonium hexfluorophosphate (Bu4NPF6) and the
measurements were made in acetonitrile.

Plasmid Photocleavage. Buffered solution of pUC18 and pUC18/complex II or
complex III at a ratio of 10:1 bp/complex were placed in a quartz cuvette and
irradiated with a 300W Mercury Arc Lamp (Newport) equipped with the
appropriate filter. Samples were taken at 10 minutes over an 80 minute period
and run in 1% agarose gel by applying 224V for 45 minutes in approximately
300mL of Tris buffer solution. Gels were stained with ethidium bromide and
photographed using UV illumination.

Results and Discussion

The original reaction of the isoquinol pyrrole was designed to create a porphyrin
ring with the aldehydes incorporated. When we ran the elemental analysis, mass
spectrum, NMR, and UV/vis spectrum we realized that we did not create a
porphyrin. The NMR looked very similar to the starting isoquinol pyrrole. The
UV/vis spectrum had a strong soret band but lacked any Q bands which should be
there for a porphyrin. The elemental analysis and mass spectrum made it clear
that we had created a new novel compound that was not a porphyrin. We decided
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to try the reaction again and got the same results. Since the aldehyde nor the
boron trifluoride dietherate were not incorporated in the compound we wondered
if they were necessary for the reaction to take place. We first took out the
aldehyde, reran the rest of the reaction, and the compound was not created. Next
we kept the aldehyde but took out the boron trifluoride dietherate and the
compound was still not created. Finally, we took out both the aldehyde and the
boron trifluoride dietherate and the reaction was unsuccessful. We know that
both the aldehyde and the boron trifluoride dietherate are necessary for the
reaction although we are unable to explain why or how the reaction takes place.
We decided to test the compound due to its great absorption properties.

Compound I

Compound II

Figure 1 shows the ultraviolet visible (UV/vis spec) spectroscopy that we
obtained on the compound. To get the compound in solution, we added methanol
to dissolve the compound and then filled up the rest of the 25 mL flask with
acetonitrile. The spectroscopy was obtained at room temperature. The red line is
the compound in solution without acid and the blue line is the compound in
solution with a couple drops of trifluoroacetic acid. The red line has strong
absorption from 500-600 nm and is very broad. We propose that the broadness of
the peak is due to stacking of the molecules in solution. Since the compound is
planar and very conjugated, hydrophobic interactions are possible between
molecules. The blue band is not broad and we believe that the positively charged
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molecules do not interact as much and do not make the peak broad. The blue
band is red-shifted, or shifted to the right. We believe that this could be due to
two different hypotheses. The first one is that the protonation of the hydroxyl
group that is attached to the nitrogen ring without a double bond (right most
nitrogen ring in the figure) creates a good leaving group. The water molecule
leaves and the adjacent hydrogen gets abstracted from the nitrogen to create a
double bond. The double bond increases the conjugation of the system that was
previously not there and the increase in the conjugation requires lower energy to
excite it (red-shift). The other hypothesis is that protonating one of the isoquinol
nitrogens creates an electronegative pull on the ring. Since the rings are
connected via single bonds, the conformation is continually shifting and changing.
When the rings rotate they occasionally align with each other. When the quinol
nitrogen gets protonated, this increases the electronegativity of that ring and when
it aligns with the adjacent ring interacts with the ring and makes that
conformation preferable. By making the conformation more preferable and
probable, the rings can essentially increase the conjugation system by the
interaction that occurs. This increase in overlapping causes the red-shift.

Figure 1. UV/Vis of Compound I. Red line is without acid. Blue line is after addition of
TFA.
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Figure 2 shows the UV/vis and fluorescence of the compound. The red line is the
UV/vis and the green line is the fluorescence. The fluorescence band is the result
of exciting the compound at 530 nm. The compound fluoresced well into the
600-700nm range. The fluorescence of this compound is a good sign for its
availability to be used as a PDT agent.

Figure 2. Red line is the UV/Vis of Compound I. Green line is the fluorescence of
Compound I.

Cyclic voltammetry (CV) in the liquid phase was performed on the compound and
the ruthenated compound. In Figure 3,the CV of compound I is shown.
Anodically, there is a large irreversible oxidation wave of the compound around
0.8-1.0 V vs. Ag/AgCl. Cathodically there is a one-electron reduction of the
compound.
Cyclic voltammetry of compound II is shown in Figure 4. Anodically there is a
reversible redox couple at 0.8 V vs. Ag/AgCl that was not present in the nonruthenated CV and is due to the Ru(III/II) couple. It does not look reversible but
that is because it is overlapped by the large irreversible wave of the ligand.
Cathodically there is a reduction wave that wasn’t previously there that is due to
the bipyridal groups that are coordinated to the rutheniums.
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Figure 3. Cyclic voltammogram of compound I in acetonitrile with tetra-butly
ammonium hexafluorophosphate as supporting electrolyte. The working electrode is
glassy carbon, scan rate = 50 mV/s.

Figure 4. Cyclic voltammogram of compound I in acetonitrile with tetra-butly
ammonium hexafluorophosphate as supporting electrolyte. The working electrode is
glassy carbon, scan rate = 50 mV/s.
Photocleavage studies were performed with aqueous solutions of circular plasmid
DNA and the ruthenated compound at a ratio 10:1 DNA base pairs to compound.
Samples were removed at ten minute intervals and gel electrophoresis was
performed in order to determine the ability of the ruthenated compound to
photocleave DNA. There was a 420nm filter lens on the lamp. This made sure
that no wavelengths lower than 420nm were allowed to penetrate the cuvette. The
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lower on the gel the bands are means that the DNA are not nicked or less nicked.
The first band (farthest left) is the control that contains just plasmid, water, and
dye. The second band (second farthest left) is the control that contains plasmid,
water, dye, and compound before being irradiated with light and since the band is
so far down, this means that the compound does not affect the DNA in the dark.
Every other band is after a ten minute interval. So the third band is after ten
minutes, the fourth band is after twenty minutes or irradiation and so forth. The
ruthenated compound was able to efficiently nick the plasmid DNA completely
after the full eighty minutes due to the lack of the lower band. This is excellent
data but the PDT window was not achieved. When we put the 550nm filter, the
ruthenated compound was not able to photocleave the plasmid DNA. We propose
that the addition of the rutheniums quenched the absorption properties of the
ligand. Due to the quenching, higher energy wavelengths are required for the
type II photocleavage to occur. This left shift of the absorption means that the
compound is not in the PDT window and not ideal. We decided to find a different
way to increase the solubility of the compound that would not quench the
absorption properties.
1

2

3

4

5

6

7

8

9

10

Figure 5. Gel electrophoresis of circular plasmid DNA (pUC18) in the presence of
complex I (lanes 2-10) and without complex I (lane 1) irradiated with a 300 W mercury
arc lamp filtered to allow only light of 420 nm and higher to penetrate, samples taken at
10 min intervals.

To eliminate the luminescent quenching of the ruthenium polypyridyl groups but
still maintain water solubility compound I was reacted with p-methyl-toluene
sulfonate giving compound III.
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The methylated compound’s uv/vis and fluorescence is shown below. The red
band is just the methylated compound’s UV/vis. It has strong absorption from
450-650nm. The blue band is the fluorescence of the compound which
fluorescences well into the PDT window. This graph implies that the methyl
groups do not quench the absorption properties of the ligand. Photocleavage
studies are required to prove that the methylated compound can still perform
photodynamic therapy in the PDT window.

Figure 6. UV/vis (red line) and fluorescence (blue line) of the methylated
polyisoquinoline.
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Figure 7 displays the gel that was created during the photocleavage study when
using compound III. The ratio of base pairs to compound is 5:1 and we extracted
samples over ten minute intervals again, then used gel electrophoresis to
determine the efficiency of the compound to photocleave DNA. We used a
550nm filter for this experiment and the compound did not quench the absorption
properties of the compound as shown by the nicked bands that did not travel as far
in the gel. Just like the ruthenated compound photocleavage experiment, the two
controls are the same and are the farthest on the left and these lanes show that the
DNA was not affected by the compound in the dark. After eighty minutes of
irradiation essentially all the plasmid is nicked. Since the 550 nm filter was used,
we know that no wavelength less than 550 nm was able to excite the compound so
the compound was not quenched by the methyl groups and it is still able to be
excited in the PDT window or very close to it. This photocleavage study proves
how important this compound is, it is water soluble and cleaves in the PDT
window.
1
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Figure 7. Gel electrophoresis of circular plasmid DNA (pUC18) in the presence of
complex I (lanes 2-10) and without complex I (lane 1) irradiated with a 300 W mercury
arc lamp filtered to allow only light of 550 nm and higher to penetrate, samples taken at
10 min intervals.

Conclusions
The initial desired compound was not obtained, instead a novel compound with an
extended conjugated system has been synthesized in high yield and with great
absorption properties. Ruthenation of the compound has been shown to photonick
plasmid DNA when irradiated with wavelengths greater than 420 nm. When
irradiated with wavelengths greater than 550nm the rutheniums have been shown
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to quench the absorption properties and disrupt the ability of the molecule to
photocleave the plasmid DNA. Methylation of the compound yielded a
compound that was water soluble with great absorption and fluorescence in the
PDT window. The methylated compound photonicked plasmid DNA at
wavelengths longer than 550 nm which means that the addition of the methyl
groups do not quench the absorption of the ligand. Further studies are being
performed to elucidate the mechanism of the reaction with the goal of
understanding what is happening chemically and to synthesize more of these
novel compounds to be used in PDT. Also, to determine the PDT effectiveness of
the compound in normal cells and cancer cells.
Acknowledgement
The author would like to thank his advisor, Dr. Shawn Swavey for his amazing
guidance, teaching, and friendship. I would also like to thank Dr. Benin for his
help with Boron NMR and always being willing to answer any questions that
arose. Finally, I would like to thank the University of Dayton Chemistry and
Honors departments for their generous contributions to this project.

References
1. Frazier, Claude C. "Photodynamic Therapy In Dermatology." International
Journal Of Dermatology 35.5 (1996): 312. Publisher Provided Full Text
Searching File. Web. 24 Mar. 2014.
2. Michel, et al. "Photodynamic Therapy (PDT) For Oesophageal Cancers." European
Journal Of Cancer Care 8.(1999): 20-24.Academic Search Complete. Web. 24
Mar. 2014.
3. Hsi, R.A., D.I. Rosenthal, and E. Glatstein. "Photodynamic Therapy In The
Treatment Of Cancer: Current State Of The Art." Drugs 57.5 (1999): 725734. SPORTDiscus with Full Text. Web. 24 Mar. 2014.
4. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl
Cancer Inst. 1998;90:889-950.
5. Hsi, R.A., D.I. Rosenthal, and E. Glatstein. "Photodynamic Therapy In The
Treatment Of Cancer: Current State Of The Art." Drugs 57.5 (1999): 725734. SPORTDiscus with Full Text. Web. 24 Mar. 2014.
6. Allison, Ron R., and Claudio H. Sibata. "Oncologic Photodynamic Therapy
Photosensitizers: A Clinical Review." Photodiagnosis & Photodynamic
Therapy 7.2 (2010): 61. Supplemental Index. Web. 25 Mar. 2014.
7. J.C., Mazière, Morlière P., and Santus R. "Invited Review: New Trends In
Photobiology. The Role Of The Low Density Lipoprotein Receptor Pathway In
The Delivery Of Lipophilic Photosensitizers In The Photodynamic Therapy Of

P a g e | 15

Tumours." Journal Of Photochemistry & Photobiology, B: Biology 8.(n.d.): 351360. ScienceDirect. Web. 24 Mar. 2014.
8. Agostinis, Patrizia, et al. "Photodynamic therapy of cancer: an update." CA: a
cancer journal for clinicians 61.4 (2011): 250-281.
9. Sharman, W. M.; Allen, C.M.; van Lier, J.E. Drug Discovery Today 1999, 4, 507.
10. DNA Interaction and Photocleavage Properties of Porphyrins Containing Cationic
Substituents at the Peripheral Position Sashikumar Mettath,†, Benjamin R.
Munson,† and, and Ravindra K. Pandey*,†,‡Bioconjugate Chemistry 1999 10 (1),
94-102
11. In Vitro Demonstration of Apoptosis Mediated Photodynamic Activity and NIR
Nucleus Imaging through a Novel Porphyrin Suneesh C. Karunakaran, P. S.
Saneesh Babu, Bollapalli Madhuri, Betsy Marydasan, Albish K. Paul, Asha S.
Nair, K. Sridhar Rao, Alagar Srinivasan, Tavarekere K. Chandrashekar, Ch.
Mohan Rao, Radhakrishna Pillai, and Danaboyina Ramaiah ACS Chemical
Biology 2013 8 (1), 127-132
12. Activatable Photosensitizers for Imaging and Therapy Jonathan F. Lovell, Tracy
W. B. Liu, Juan Chen, and Gang Zheng Chemical Reviews 2010 110 (5), 28392857
13. O'Connor, Aisling E., William M. Gallagher, and Annette T. Byrne. "Porphyrin
And Nonporphyrin Photosensitizers In Oncology: Preclinical And Clinical
Advances In Photodynamic Therapy." Photochemistry & Photobiology 85.5
(2009): 1053-1074. Academic Search Complete. Web. 26 Mar. 2014.
14. Yang, Pei-Wen, et al. "The Effects Of Photofrin-Mediated Photodynamic Therapy
On The Modulation Of EGFR In Esophageal Squamous Cell Carcinoma
Cells." Lasers In Medical Science 28.2 (2013): 605-614. MEDLINE with Full
Text. Web. 26 Mar. 2014.
15. Lash, Timothy D., and Virajkumar Gandhi. "Porphyrins With Exocyclic Rings.
15. Synthesis Of Quino- And Isoquinoporphyrins, Aza Analogues..." Journal Of
Organic Chemistry 65.23 (2000): 8020. Academic Search Complete. Web. 24
Mar. 2014.
16. Ormond, Alexandra B., and Harold S. Freeman. "Dye Sensitizers For
Photodynamic Therapy." Materials (1996-1944) 6.3 (2013): 817-840. Academic
Search Complete. Web. 27 Mar. 2014.
17. Pushpan, S K, et al. "Porphyrins In Photodynamic Therapy - A Search For Ideal
Photosensitizers." Current Medicinal Chemistry. Anti-Cancer Agents 2.2 (2002):
187-207. MEDLINE with Full Text. Web. 27 Mar. 2014.
18. Barun, V., et al. "Absorption Spectra And Light Penetration Depth Of Normal
And Pathologically Altered Human Skin." Journal Of Applied Spectroscopy 74.3
(2007): 430-439. Academic Search Complete. Web. 27 Mar. 2014.
19. Sullivan, B.P.; Salmon, D.J.; Meyer, T.J. Inorg. Chem. 1978, 17, 3334.

